Schering-Plough's successful allergy medication gets an updated ad campaign. The Nasonex Bee is buzzing a new tune. Schering-Plough is working with BBDO to update its successful Nasonex (mometasone ...

Schering-Plough reported that the FDA has approved a new scent-free formulation of Nasonex prescription nasal inhaled steroid. Nasonex remains the first and only once-daily prescription nasal inhaled ...

Although the court ruled that the patent is valid, it also said that Apotex’s product would not infringe on the patent. Merck had filed a patent infringement suit against Apotex in December 2009. The ...

April is here, and it feels like everyone (and their mother) is congested. Allergists warn this could be an especially heavy pollen season, which means your allergy symptoms might hit harder than ...

WHITEHOUSE STATION, N.J. — Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

IAG Research released its top-10 list of most-recalled new pharma ads of 2007. Many familiar faces top the list, including the Nasonex bee, Abe Lincoln, and Dr. Jarvik, but how many of those faces ...

The FDA's new proposed guidelines on drug advertising read like a full-employment act for medical copywriters and graphic designers: they control font size, white space, context, contrast, placement, ...

A once-daily dose of Schering-Plough’s allergy drug, Nasonex (mometasone), is safe and effective for the treatment of nasal polyps and nasal congestion related to the condition, according to new ...

Mometasone (as furoate monohydrate) 50mcg/spray; contains benzalkonium chloride. Not for treating asthma. Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed.

Bear Stearns maintained an "underperform" rating on Schering-Plough as the price spread widens between generic and branded versions of Flonase, an allergy drug made by competitor GlaxoSmithKline .